|
1
|
Hobert O and Westphal H: Functions of
LIM-homeobox genes. Trends Genet. 16:75–83. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dawid IB: LIM domain proteins. C R Acad
Sci. 3:295–306. 1995.
|
|
3
|
Bach I: The LIM domain: regulation by
association. Mech Dev. 91:5–17. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Glenn DJ and Maurer RA: MRG1 binds to the
LIM domain of Lhx2 and may function as a coactivator to stimulate
glycoprotein hormone alpha-subunit gene expression. J Biol Chem.
274:36159–36167. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Howard PW and Maurer RA: Identification of
a conserved protein that interacts with specific LIM homeodomain
transcription factors. J Biol Chem. 275:13336–13342. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ostendorff HP, Peirano RI, Peters MA, et
al: Ubiquitination-dependent cofactor exchange on LIM homeodomain
transcription factors. Nature. 416:99–103. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shawlot W and Behringer RR: Requirement
for Lim1 in head-organizer function. Nature. 374:425–430. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Karavanov AA, Karavanova I, Perantoni A
and Dawid IB: Expression pattern of the rat Lim-1 homeobox gene
suggests a dual role during kidney development. Int J Dev Biol.
42:61–66. 1998.PubMed/NCBI
|
|
9
|
Kobayashi A, Kwan KM, Carroll TJ, McMahon
AP, Mendelsohn CL and Behringer RR: Distinct and sequential
tissue-specific activities of the LIM-class homeobox gene Lim1 for
tubular morphogenesis during kidney development. Development.
132:2809–2823. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen YT, Kobayashi A, Kwan KM, Johnson RL
and Behringer RR: Gene expression profiles in developing nephrons
using Lim1 metanephric mesenchyme-specific conditional mutant mice.
BMC Nephrol. 7:12006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Guertl B, Senanayake U, Nusshold E, et al:
Lim1, an embryonal transcription factor, is absent in multicystic
renal dysplasia, but reactivated in nephroblastomas. Pathobiology.
78:210–219. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dormoy V, Béraud C, Lindner V, Thomas L,
Coquard C, Barthelmebs M, Jacqmin D, Lang H and Massfelder T:
LIM-class homeobox gene Lim1, a novel oncogene in human renal cell
carcinoma. Oncogene. 30:1753–1763. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xu Y, Baldassare M, Fisher P, et al: LH-2:
a LIM/homeodomain gene expressed in developing lymphocytes and
neural cells. Proc Natl Acad Sci USA. 90:227–231. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Richter K, Pinto do OP, Hägglund AC,
Wahlin A and Carlsson L: Lhx2 expression in hematopoietic
progenitor/stem cells in vivo causes a chronic myeloproliferative
disorder and altered globin expression. Haematologica.
88:1336–1347. 2003.PubMed/NCBI
|
|
15
|
Nadal N, Chapiro E, Flandrin-Gresta P, et
al: LHX2 deregulation by juxtaposition with the IGH
locus in a pediatric case of chronic myeloid leukemia in B-cell
lymphoid blast crisis. Leuk Res. 36:195–198. 2012. View Article : Google Scholar
|
|
16
|
Wu HK, Heng HH, Siderovski DP, et al:
Identification of a human LIM-Hox gene, hLH-2, aberrantly expressed
in chronic myelogenous leukaemia and located on 9q33–34.1.
Oncogene. 12:1205–1212. 1996.PubMed/NCBI
|
|
17
|
Wu HK and Minden MD: Transcriptional
activation of human LIM-HOX gene, hLH-2, in chronic
myelogenous leukemia is due to a cis-acting effect of
Bcr-Abl. Biochem Biophys Res Commun. 233:806–812.
1997.PubMed/NCBI
|
|
18
|
Gorantla B, Asuthkar S, Rao JS, Patel J
and Gondi CS: Suppression of the uPAR-uPA system retards
angiogenesis, invasion, and in vivo tumor development in
pancreatic cancer cells. Mol Cancer Res. 9:377–389. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tiede S and Paus R: Lhx2-decisive role in
epithelial stem cell maintenance, or just the ‘tip of the iceberg’?
Bioessays. 28:1157–1160. 2006.PubMed/NCBI
|
|
20
|
Abate-Shen C: Deregulated homeobox gene
expression in cancer: cause or consequence? Nat Rev Cancer.
2:777–785. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rahmatpanah FB, Carstens S, Guo J, et al:
Differential DNA methylation patterns of small B-cell lymphoma
subclasses with different clinical behavior. Leukemia.
20:1855–1862. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim MS, Lee J, Oh T, et al: Genome-wide
identification of OTP gene as a novel methylation marker of
breast cancer. Oncol Rep. 27:1681–1688. 2012.PubMed/NCBI
|
|
23
|
Kamalakaran S, Varadan V, Giercksky
Russnes HE, et al: DNA methylation patterns in luminal breast
cancers differ from non-luminal subtypes and can identify relapse
risk independent of other clinical variables. Mol Oncol. 5:77–92.
2011. View Article : Google Scholar
|
|
24
|
Rauch T, Li H, Wu X and Pfeifer GP:
MIRA-assisted microarray analysis, a new technology for the
determination of DNA methylation patterns, identifies frequent
methylation of homeodomain-containing genes in lung cancer cells.
Cancer Res. 66:7939–7947. 2006. View Article : Google Scholar
|
|
25
|
Sharma K, Sheng HZ, Lettieri K, et al: LIM
homeodomain factors Lhx3 and Lhx4 assign subtype identities for
motor neurons. Cell. 95:817–828. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sheng HZ, Zhadanov AB, Mosinger B Jr, et
al: Specification of pituitary cell lineages by the LIM homeobox
gene Lhx3. Science. 272:1004–1007. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sheng HZ, Moriyama K, Yamashita T, et al:
Multistep control of pituitary organogenesis. Science.
278:1809–1812. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Thaler JP, Lee SK, Jurata LW, Gill GN and
Pfaff SL: LIM factor Lhx3 contributes to the specification of motor
neuron and interneuron identity through cell-type-specific
protein-protein interactions. Cell. 110:237–249. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dietrich D, Lesche R, Tetzner R, et al:
Analysis of DNA methylation of multiple genes in microdissected
cells from formalin-fixed and paraffin-embedded tissues. J
Histochem Cytochem. 57:477–489. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li H, Witte DP, Branford WW, et al: Gsh-4
encodes a LIM-type homeodomain, is expressed in the developing
central nervous system and is required for early postnatal
survival. EMBO J. 13:2876–2885. 1994.PubMed/NCBI
|
|
31
|
Liu Y, Fan M, Yu S, et al: cDNA cloning,
chromosomal localization and expression pattern analysis of human
LIM-homeobox gene LHX4. Brain Res. 928:147–155. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Machinis K, Pantel J, Netchine I, et al:
Syndromic short stature in patients with a germline mutation in the
LIM homeobox LHX4. Am J Hum Genet. 69:961–968. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Raetzman LT, Ward R and Camper SA:
Lhx4 and Prop1 are required for cell survival and
expansion of the pituitary primordia. Development. 129:4229–4239.
2002.PubMed/NCBI
|
|
34
|
Kawamata N, Sakajiri S, Sugimoto KJ, Isobe
Y, Kobayashi H and Oshimi K: A novel chromosomal translocation
t(1;14)(q25;q32) in pre-B acute lymphoblastic leukemia involves the
LIM homeo-domain protein gene, Lhx4. Oncogene. 21:4983–4991. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yamaguchi M, Yamamoto K and Miura O:
Aberrant expression of the LHX4 LIM homeobox gene caused by
t(1;14)(q25;q32) in chronic myelogenous leukemia in biphenotypic
blast crisis. Genes Chromosomes Cancer. 38:269–273. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
de Bruijn DR, van Dijk AH, Willemse MP and
van Kessel AG: The C terminus of the synovial sarcoma-associated
SSX proteins interacts with the LIM homeobox protein LHX4.
Oncogene. 27:653–662. 2008.PubMed/NCBI
|
|
37
|
Goc A, Kochuparambil ST, Al-Husein B,
Al-Azayzih A, Mohammad S and Somanath PR: Simultaneous modulation
of the intrinsic and extrinsic pathways by simvastatin in mediating
prostate cancer cell apoptosis. BMC Cancer. 12:4092012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hung TM, Hu RH, Ho CM, et al:
Downregulation of alpha-fetoprotein expression by LHX4: a critical
role in hepatocarcinogenesis. Carcinogenesis. 32:1815–1823. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhao Y, Hermesz E, Yarolin MC and Westphal
H: Genomic structure, chromosomal localization and expression of
the human LIM-homeobox gene LHX5. Gene. 260:95–101. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sheng HZ, Bertuzzi S, Chiang C, et al:
Expression of murine Lhx5 suggests a role in specifying the
forebrain. Dev Dyn. 208:266–277. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhao Y, Sheng HZ, Amini R, et al: Control
of hippocampal morphogenesis and neuronal differentiation by the
LIM homeobox gene Lhx5. Science. 284:1155–1158. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Grigoriou M, Tucker AS, Sharpe PT and
Pachnis V: Expression and regulation of Lhx6 and
Lhx7, a novel subfamily of LIM homeodomain encoding genes,
suggests a role in mammalian head development. Development.
125:2063–2074. 1998.
|
|
43
|
Estécio MR, Youssef EM, Rahal P, et al:
LHX6 is a sensitive methylation marker in head and neck carcinomas.
Oncogene. 25:5018–5026. 2006.PubMed/NCBI
|
|
44
|
Jung S, Jeong D, Kim J, et al: Epigenetic
regulation of the potential tumor suppressor gene, hLHX6.1,
in human cervical cancer. Int J Oncol. 38:859–869. 2011.PubMed/NCBI
|
|
45
|
Jung S, Jeong D, Kim J, et al: The role of
hLHX6-HMR as a methylation biomarker for early diagnosis of
cervical cancer. Oncol Rep. 23:1675–1682. 2010.
|
|
46
|
Failli V, Rogard M, Mattei MG, Vernier P
and Rétaux S: Lhx9 and Lhx9α LIM-homeodomain factors: genomic
structure, expression patterns, chromosomal localization, and
phylogenetic analysis. Genomics. 64:307–317. 2000.
|
|
47
|
Vladimirova V, Mikeska T, Waha A, et al:
Aberrant methylation and reduced expression of LHX9 in malignant
gliomas of childhood. Neoplasia. 11:700–711. 2009.PubMed/NCBI
|
|
48
|
Bennett LB, Schnabel JL, Kelchen JM, et
al: DNA hypermethylation accompanied by transcriptional repression
in follicular lymphoma. Genes Chromosomes Cancer. 48:828–841. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Karlsson O, Thor S, Norberg T, Ohlsson H
and Edlund T: Insulin gene enhancer binding protein Isl-1 is a
member of a novel class of proteins containing both a homeo-and a
Cys His domain. Nature. 344:879–882. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Ahlgren U, Pfaff SL, Jessell TM, Edlund T
and Edlund H: Independent requirement for ISL1 in formation of
pancreatic mesenchyme and islet cells. Nature. 385:257–260. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yamada T, Pfaff SL, Edlund T and Jessell
TM: Control of cell pattern in the neural tube: motor neuron
induction by diffusible factors from notochord and floor plate.
Cell. 73:673–686. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Jensen J: Gene regulatory factors in
pancreatic development. Dev Dyn. 229:176–200. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Dong J, Asa SL and Drucker DJ: Islet cell
and extrapancreatic expression of the LIM domain homeobox gene
isl-1. Mol Endocrinol. 5:1633–1641. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Graham RP, Shrestha B, Caron BL, et al:
Islet-1 is a sensitive but not entirely specific marker for
pancreatic neuroendocrine neoplasms and their metastases. Am J Surg
Pathol. 37:399–405. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Koo J, Mertens RB, Mirocha JM, Wang HL and
Dhall D: Value of Islet 1 and PAX8 in identifying metastatic
neuroendocrine neoplasms of pancreatic origin. Mod Pathol.
25:893–902. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Schmitt AM, Riniker F, Anlauf M, et al:
Islet 1 (Isl1) expression is a reliable marker for pancreatic
endocrine neoplasms and their metastases. Am J Surg Pathol.
32:420–425. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Hermann G, Konukiewitz B, Schmitt A,
Perren A and Klöppel G: Hormonally defined pancreatic and duodenal
neuroendocrine tumors differ in their transcription factor
signatures: expression of ISL1, PDX1, NGN3, and CDX2. Virchows
Arch. 459:147–154. 2011. View Article : Google Scholar
|
|
58
|
Cheung IY, Feng Y, Gerald W and Cheung NK:
Exploiting gene expression profiling to identify novel minimal
residual disease markers of neuroblastoma. Clin Cancer Res.
14:7020–7027. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Chizhikov VV, Lindgren AG, Mishima Y, et
al: Lmx1a regulates fates and location of cells originating from
the cerebellar rhombic lip and telencephalic cortical hem. Proc
Natl Acad Sci USA. 107:10725–10730. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Cai J, Donaldson A, Yang M, German MS,
Enikolopov G and Iacovitti L: The role of Lmx1a in the
differentiation of human embryonic stem cells into midbrain
dopamine neurons in culture and after transplantation into a
Parkinson’s disease model. Stem Cell. 27:220–229. 2009.PubMed/NCBI
|
|
61
|
Lin CK, Chao TK, Lai HC and Lee HS: LMX1A
as a prognostic marker in ovarian mucinous cystadenocarcinoma. Am J
Clin Pathol. 137:971–977. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Tsai WC, Lee HS, Lin CK, Chen A, Nieh S
and Ma HI: The association of osteopontin and LMX1A expression with
World Health Organization grade in meningiomas and gliomas.
Histopathology. 61:844–856. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Tsai WC, Lin CK, Yang YS, et al: The
correlations of LMX1A and osteopontin expression to the
clinicopathologic stages in pancreatic adenocarcinoma. Appl
Immunohistochem Mol Morphol. 21:395–400. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Liu CY, Chao TK, Su PH, et al:
Characterization of LMX-1A as a metastasis suppressor in cervical
cancer. J Pathol. 219:222–231. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Lai HC, Lin YW, Huang TH, et al:
Identification of novel DNA methylation markers in cervical cancer.
Int J Cancer. 123:161–167. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Lai HC, Lin YW, Huang RL, et al:
Quantitative DNA methylation analysis detects cervical
intraepithelial neoplasms type 3 and worse. Cancer. 116:4266–4274.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Chao TK, Yo YT, Liao YP, et al:
LIM-homeobox transcription factor 1, alpha (LMX1A) inhibits
tumourigenesis, epithelial-mesenchymal transition and stem-like
properties of epithelial ovarian cancer. Gynecol Oncol.
128:475–482. 2013. View Article : Google Scholar
|
|
68
|
Su HY, Lai HC, Lin YW, et al: An
epigenetic marker panel for screening and prognostic prediction of
ovarian cancer. Int J Cancer. 124:387–393. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Zhao Y, Guo S, Sun J, et al: Methylcap-seq
reveals novel DNA methylation markers for the diagnosis and
recurrence prediction of bladder cancer in a Chinese population.
PLoS One. 7:e351752012. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Dong W, Feng L, Xie Y, Zhang H and Wu Y:
Hypermethylation-mediated reduction of LMX1A expression in gastric
cancer. Cancer Sci. 102:361–366. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Paz MF, Wei S, Cigudosa JC, et al: Genetic
unmasking of epigenetically silenced tumor suppressor genes in
colon cancer cells deficient in DNA methyltransferases. Hum Mol
Genet. 12:2209–2219. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Chen H, Lun Y, Ovchinnikov D, et al: Limb
and kidney defects in Lmx1b mutant mice suggest an
involvement of LMX1B in human nail patella syndrome. Nat
Genet. 19:51–55. 1998.
|
|
73
|
Riddle RD, Ensini M, Nelson C, Tsuchida T,
Jessell TM and Tabin C: Induction of the LIM homeobox gene
Lmx1 by WNT7a establishes dorsoventral pattern in the
vertebrate limb. Cell. 83:631–640. 1995.PubMed/NCBI
|
|
74
|
Rieger ME, Sims AH, Coats ER, Clarke RB
and Briegel KJ: The embryonic transcription cofactor LBH is a
direct target of the Wnt signaling pathway in epithelial
development and in aggressive basal subtype breast cancers. Mol
Cell Biol. 30:4267–4279. 2010. View Article : Google Scholar
|
|
75
|
Kengaku M, Capdevila J, Rodriguez-Esteban
C, et al: Distinct WNT pathways regulating AER formation and
dorsoventral polarity in the chick limb bud. Science.
280:1274–1277. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Clevers H: Wnt/β-catenin signaling in
development and disease. Cell. 127:469–480. 2006.
|
|
77
|
Millen KJ, Millonig JH and Hatten ME: Roof
plate and dorsal spinal cord dl1 interneuron development in the
dreher mutant mouse. Dev Biol. 270:382–392. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Chizhikov VV and Millen KJ: Control of
roof plate formation by Lmx1a in the developing spinal cord.
Development. 131:2693–2705. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Kishigami S and Mishina Y: BMP signaling
and early embryonic patterning. Cytokine Growth Factor Rev.
16:265–278. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Dormoy V, Jacqmin D, Lang H and Massfelder
T: From development to cancer: lessons from the kidney to uncover
new therapeutic targets. Anticancer Res. 32:3609–3617.
2012.PubMed/NCBI
|
|
81
|
Sato A and Shibuya H: WNK signaling is
involved in neural development via Lhx8/Awh expression. PLoS One.
8:e553012013. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Moriguchi T, Urushiyama S, Hisamoto N, et
al: WNK1 regulates phosphorylation of cation-chloride-coupled
cotransporters via the STE20-related kinases, SPAK and OSR1. J Biol
Chem. 280:42685–42693. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Vitari AC, Deak M, Morrice NA and Alessi
DR: The WNK1 and WNK4 protein kinases that are mutated in Gordon’s
hypertension syndrome phosphorylate and activate SPAK and OSR1
protein kinases. Biochem J. 391:17–24. 2005.PubMed/NCBI
|
|
84
|
Moniz S and Jordan P: Emerging roles for
WNK kinases in cancer. Cell Mol Life Sci. 67:1265–1276. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Veríssimo F and Jordan P: WNK kinases, a
novel protein kinase subfamily in multi-cellular organisms.
Oncogene. 20:5562–5569. 2001.PubMed/NCBI
|
|
86
|
Tu SW, Bugde A, Luby-Phelps K and Cobb MH:
WNK1 is required for mitosis and abscission. Proc Natl Acad Sci
USA. 108:1385–1390. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Sun X, Gao L, Yu RK and Zeng G:
Down-regulation of WNK1 protein kinase in neural progenitor cells
suppresses cell proliferation and migration. J Neurochem.
99:1114–1121. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Moniz S and Jordan P: Emerging roles for
WNK kinases in cancer. Cell Mol Life Sci. 67:1265–1276. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Cohen ED, Wang Z, Lepore JJ, et al:
Wnt/β-catenin signaling promotes expansion of Isl-1-positive
cardiac progenitor cells through regulation of FGF signaling. J
Clin Invest. 117:1794–1804. 2007.
|
|
90
|
Liem KF Jr, Jessell TM and Briscoe J:
Regulation of the neural patterning activity of sonic hedgehog by
secreted BMP inhibitors expressed by notochord and somites.
Development. 127:4855–4866. 2000.PubMed/NCBI
|
|
91
|
Chizhikov VV and Millen KJ: Control of
roof plate development and signaling by Lmx1b in the caudal
vertebrate CNS. J Neurosci. 24:5694–5703. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Chizhikov VV and Millen KJ: Control of
roof plate formation by Lmx1a in the developing spinal cord.
Development. 131:2693–2705. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Alexandre P, Bachy I, Marcou M and Wassef
M: Positive and negative regulations by FGF8 contribute to midbrain
roof plate developmental plasticity. Development. 133:2905–2913.
2006. View Article : Google Scholar : PubMed/NCBI
|
